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Abstract
Recent technological advances in cell reprogramming by generation of induced pluripotent stem cells (iPSC) offer major
perspectives in disease modelling and future hopes for providing novel stem cells sources in regenerative medicine.
However, research on iPSC still requires refining the criteria of the pluripotency stage of these cells and exploration of their
equivalent functionality to human embryonic stem cells (ESC). We report here on the use of infrared microspectroscopy to
follow the spectral modification of somatic cells during the reprogramming process. We show that induced pluripotent
stem cells (iPSC) adopt a chemical composition leading to a spectral signature indistinguishable from that of embryonic
stem cells (ESC) and entirely different from that of the original somatic cells. Similarly, this technique allows a distinction to
be made between partially and fully reprogrammed cells. We conclude that infrared microspectroscopy signature is a novel
methodology to evaluate induced pluripotency and can be added to the tests currently used for this purpose.
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Introduction
The last decade of stem cell research has witnessed paramount
milestones from the first description of human ESC (hESC) [1] to
the recent reprogramming techniques of adult stem cells [2].
hESC exhibit similarities with iPSC in terms of pluripotency and
differentiation potential [2,3]. However, despite their pluripoten-
cy, iPSC might not be entirely similar to hESC, especially with
regard to their functional status. Indeed, a recent study has shown
a gene signature and micro-RNA signature of iPSC distinct from
that of hESC [4,5]. Recent data reveal also an epigenetic memory
preserved in iPSC according to the somatic cell of origin which
will hinder or facilitate their differentiation as a function of this
memory [6,7]. Pluripotency is assessed directly by phenotypic
criteria or indirectly by functional assays such as teratoma
induction, or by global genomic approaches. However, method-
ologies allowing their identification using biophysical characteris-
tics of the cells are lacking.
In this work, we explored the chemical and metabolic
components of iPSC and ESC by using the Fourier Transform
Infrared (FTIR) spectroscopy, combined with a high brilliance
synchrotron radiation source [8]. Synchrotron infrared micro-
spectroscopy is a promising technique for biomedical and
biological studies at subcellular resolution allowing the analysis
of several cell components such as polysaccharides, nucleic acids,
protein and lipid contents in terms of the spectra they generate
(Fig. 1A and Table S1) while providing an excellent spectral
quality, an important prerequisite for post-statistical analysis [8].
Importantly, this description can be obtained at single cell level
and thus offers a powerful technique to explore the cellular
diversity within a cell population.
Results
We first explored a series of human iPSC that were generated
from somatic amniotic fluid cells (AFC). All of these iPSC (PB03 to
PB13) were validated for their pluripotency and have been
registered on the European registry (www.hesreg.eu). Using FTIR
microspectroscopy, we could not identify significant differences
between 6 of these iPSC and 6 human ESC lines (Fig. 1B).
We noticed that the iPSC cloud is slightly shifted along the PC2
axis indicating that iPSC accumulate more glycogen, and have a
slightly more active metabolism than the hESC lines. We
performed a multivariate prediction approach in order to confirm
that ESC and IPS cells are spectrally extremely similar. For such a
purpose, we used a PLS-DA model with a calibration set
containing more than 4000 spectra of ESC. A validation set of
505 spectra not included in the calibration set, was used for
prediction, using 6 factors explaining 98% of the spectral variance.
The PLS-DA prediction was evaluated through the computed
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The results, reported on Table S2 indicate that the prediction
model was only slightly better than the performance of a random
classifier (MCC 0.48) and correctly identified IPSC (sensitivity
83%) but failed to identify correctly ESC (specificity 63%). The
prediction accuracy relied only on the 5
th and 6
th factors each
accounting for less than 1% of the spectral variance but carrying
40% of the class difference. This confirmed that ESC and IPS cells
are spectrally extremely similar. We then wondered whether we
could identify any differences in terms of infrared spectra between
the parental somatic AFC and their iPSC derivatives. As can be
seen in Fig. 1D, AFC were found to exhibit a significant and
distinct spectral signature from that of iPSC, suggesting that the
reprogramming process modified significantly the metabolic
composition of these differentiated cells. A PLS-DA model
separated the AFC and IPS spectra from a validation set with a
MCC of 1, a perfect prediction (Table S2). The differences were
best seen using the loadings of the Principal Component Analysis
(PCA). The main differences arise from the lipid composition and
cellular concentrations (1740, 1710, 1465, 1455, 1170 cm
21),
from changes in the proteome (1650, 1635, 1550 cm
21), and from
changes in the cellular phosphorylation (1270 cm
21, 1074 cm
21).
Similarly, FTIR spectroscopy could allow efficient distinction of
murine iPSC cell line (M2A1) generated by reprogramming of
murine embryonic fibroblasts (MEF). As can be seen in Fig. 1F,
MEF exhibit a spectrum clearly different from the murine iPSC.
By using this PLS-DA model, MEF spectra can be discriminated
from the mIPS/mESC spectra with 100% sensitivity and 100%
specificity (Table S2).The murine iPSC were found to exhibit a
spectral signature similar to that of four murine ESC lines (D3,
GS2, CJ7, R1) and were not separated by using the first principal
components in the non-supervised PCA (data not shown), and in
the supervised discriminant analysis PLS-DA (Fig. 1D), or in
HCA. However, a PLS-DA model with 646 spectra of mIPSC and
mESC allowed achieving a correct identification (MCC=0.78) of
100 validation spectra using 6 factors explaining 99% of the
spectral variance.
These results prompted us to validate experimentally the
generation of a ‘‘pluripotency spectra’’ signature by reprogram-
ming strategies. To confirm these results, we devised a strategy to
generate differentiated cells from the hESC H9 and to reprogram
back these differentiated cells into the iPSC state by reprogram-
ming factors (Figure S1). Mesenchymal stem cells (MSC)
generated from H9, were characterized by phenotypic profiling
and functional properties as described [9] (Figure S2) and then
reprogrammed into iPSC. The iPSC generated from MSC-H9
(called hereafter as iPS-H9) exhibited all the markers of
pluripotency similarly to ESC including generation of teratomas
and had silenced the reprogramming transgenes Figure S3). The
spectral signatures of individual ESC-H9, MSC-H9 and iPSC-H9
cells were recorded and their spectra analyzed using pattern
recognition approaches (see Methods). The MSC-H9 spectra were
found to be clearly different from those of the ESC and iPSC
(Fig. 2A) and could be identified with 100% specificity and
sensitivity by a discriminant analysis model with a MCC of 1
(Table S2). The MSC spectra feature higher lipid-to-protein and
lower nucleic acid-to-protein ratios. Importantly, the iPSC-H9 and
ESC-H9 spectra could not be separated by unsupervised methods
(PCA, HCA) or supervised (PLS-DA) approaches using the first 3
PCs accounting for 85% of the variance. This shows that upon
reprogramming, MSC-H9 have recovered the same chemical
composition as the parental ESC-H9. However, a PLS-DA model
capturing 99% of the spectral variance (8 factors) could separate
the iPSC-H9 from the ESC-H9 with a MCC of 0.82 close to a
perfect prediction (Table S2). As for murine cells, techniques using
the most natural variance such as HCA, KMC and PCA could not
discriminate accurately between the ESC and the iPSC. However,
more sophisticated techniques such as PLS-DA were able to more
reliably separate iPSC from ESC using a small percentage of the
spectral variance (less than 1%) showing that FTIR spectroscopy
can detect the small chemical differences that persist between
those cells.
We next asked whether FTIR could discriminate bona fide iPSC
from partially reprogrammed (PR) iPSC (PB14, PB15, PB18)
characterized by the maintenance of transgene expression (Fig. S3)
or the maintenance of the GFP expression in iPSC (PB08), the
latter cell line being obtained by retroviral mediated transfer of
pluripotency gene strategy using the GFP as a selection marker.
The fully reprogrammed (FR) PB08-FR GFP-negative cells were
compared with PB08-PR GFP-positive iPSC clones. In PCA the
separation between PR and FR IPSCs spectra is carried by the
second PC (Fig. 2D) which shows an increased lipid and glycogen
storage in the IPSCs-PR . Most of iPSC-FR spectra were classified
apart from those of iPSC-PR spectra. IPCS-PR were already
engaged in the de-differentiation process and a continuum of
spectral signatures existed between the differentiated and repro-
grammed states.
Thus, FTIR microspectroscopy could also be used to separate
out the candidate fully programmed iPSC clones from the partially
programmed ones. A perfect prediction of iPSC-FR (100%
sensitivity, 100% specificity and MCC=1) could be achieved
using a PLS-DA model with 10 factors and 98% of the variance
(Table S2).
Discussion
Several reports showed that infrared spectroscopy and micro-
spectroscopy could be used to follow the differentiation state of
Figure 1. Analysis of infrared spectra obtained from human and murine ESC as compared to human and murine iPSC and the
corresponding somatic cells. (A) Representative infrared spectrum obtained by FTIR microscopy. The infrared spectrum of a cell represents an
integrated signature of the cell defined by chemical composition and metabolism that gives rise to a biochemical fingerprint of the cell identity.
(B) Comparison of iPSC and non-isogenic hESC lines by Synchrotron FTIR microscopy. Six ESC (H1, H9, HUES3, CL01, CL03, CL04) (blue) and six
unrelated iPSC cell lines (PB03, PB04, PB08, PB09, PB10, PB13) (red) were compared by MVA. The scoreplot based on PC1 and PC2 of Principal
Component Analysis (PCA) shows that iPSC and ESC spectral signatures are very similar. (C) Loading plot corresponding to the comparison of iPSC
and hESC. PC1 and PC2 show that the dispersion of iPSC and ESC spectra is related to changes in protein:nucleic acid, protein:glycogen contents, and
in the proteome. (D) Comparison of spectral signatures of human somatic amniotic fluid cells (AFC) and their iPSC derivatives. Two independent AFC
populations (blue) and their derived iPSC (PB03, PB04) (red) were compared. As can be seen in Scoreplot of the Principal Component Analysis AFC
and iPSC derived from them could be differentiated by their spectral signatures. (E) Loading plot corresponding to the comparison of AFC and their
iPSC derivatives. PC1 and PC4 allow separating AFC and iPSC spectra from changes in the lipid signal (1740, 1710, 1465, 1455, 1170 cm
21), in the
proteome signal (1650, 1635, 1550 cm
21), and in the cellular phosphorylation (1270 cm
21, 1074 cm
21). (F) Comparison of spectral signature of MEF
with the M2A1 iPSC and murine ESC. Scoreplot of the PLS-DA show a distinct and separated spectra of MEF (green), M2A1 (red) and 4 murine ESC
(CJ7, R2, D3 and GS2) (blue). M2A1 clustered with the murine ESC. (G) Loading plot corresponding to the comparison of murine iPSC and mESC. PC1
and PC2 explaining the spectral differences between murine stem cells and MEF in the proteome and nucleic acid ranges.
doi:10.1371/journal.pone.0030743.g001
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ming of differentiated cells into iPSC was never studied by this
technology.Recently,ahigh-throughputdynamicsinglecellimaging
technique describing iPSC generation has been reported [16] .The
technique that we describe is complementary of this methodology
and can be applied to large numbers of cells. We report here for the
first time, that FTIR microspectroscopy could be used to follow the
spectral signature of adult cells during reprogrammation. We
demonstrate that a differentiated cell becoming a bona fide iPSC
acquires the same metabolic features as ESC. The FTIR
microspectroscopy could therefore be a promising technique for
determiningthemetabolicfingerprintofindividualESCandiPSCin
confluent colonies due to the high spectral quality and single cell
resolution complemented byspectral patternrecognition techniques.
FTIR spectroscopy and multivariate pattern recognition also
managed to reliably identify the small chemical differences (less
than 1% of the spectral variance) between iPSC and ESC using
supervised method where class identity is known a priori.
The involvement of lipids in stem cell biology has been the
subjects of several studies, showing high lipid rafts contents of adult
and embryonic stem cells [17,18]. Stem cell manipulation
techniques with the use of synthetic lipids can modify the fate of
cells grown in culture. For instance, recent studies suggested that
ceramide was a critical cell-signaling factor for stem cell
differentiation and cell polarity, two processes at the core of
embryo development [17]. It has also been shown that ceramide
was able to maintain the pluripotency of embryonic stem cells
during culture without feeders on matrigel [19]. Our work
demonstrate that FTIR microspectroscopy is an direct and robust
method to follow the successfully reprogramming process and will
be very useful in particularly in the case of integration-free iPSC
generation. Finally, this technique can gain a wide application in
the field of stem cell research by the availability of Raman infrared
microscopy which can be accessed easily as compared to
Synchrotron based FT-IR microspectroscopy.
Materials and Methods
ESC lines
Human embryonic stem cell lines H1, H9 were obtained from
WiCell Research Institute, Madison, WI, (http:// www.wicell.org),
HUES3 from Howard Hughes Medical Institute (HUES Facility/
Melton Laboratory), CL01, CL02, and CL03 from ESTeam Paris
Sud, France (http://www.pfsc.fr). Human embryonic stem cells
were used in this study under the agreements # RE07-008R
provided by the French Biomedical Agency.
Figure 2. Identification of spectral signatures appearing during reprogrammation. (A) Comparison of spectral signature of MSC-H9 with
IPSC-H9 and parental H9. Scoreplot of the PLS-DA show a distinct and separated spectra of MSC-H9 (green), iPSC-H9 (red) and H9 (blue). H9 and iPSC-
H9 clustered together with a similar spectra. (B) Loading plot corresponding to the comparison of spectral signature of MSC-H9 with IPSC-H9 and
parental H9. PC1 and PC2 show that the difference between MSC-H9 and ESC-H9/iPSC-H9 spectra lies in the lipid:protein and in the protein:nucleic
acid contents. (C) Comparison of spectral signatures between Partially Reprogrammed (PR) and Fully Reprogrammed (FR) iPSC and AFC. Scoreplot of
the PCA of PC2 versus PC3 (representing respectively 20 and 8% of the spectral variance) using the 800–1800 and 2800–3100 cm21 ranges show a
separation between iPSC-PR (PB08-PR, PB14, PB15, PB18) and iPSC-FR (PB03, PB04, PB08-FR, PB10, PB13) with a change in lipid and glycogen storage
in the PR iPS. (D) Loading plot of the comparison of spectral signatures between Partially Reprogrammed (PR) and Fully Reprogrammed (FR) iPSC and
AFC. PC2 and PC3 illustrate the chemical variability in protein, glycogen, lipid and nucleic acid contents between AFC and iPSC at different stages of
the reprogrammation process.
doi:10.1371/journal.pone.0030743.g002
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on a feeder layer of mitomycin C inactivated mouse embryonic
fibroblasts in DMEM/F12 supplemented with 20% Knock Out
serum replacer, 1 mM L-glutamine, 0.5% penicillin/streptomycin,
100 mM 2-mercaptoethanol, 10 ng/ml basic FGF (all of them
from Invitrogen). Murine ES cell lines GS2 was kindly provided by
A. Smith (ISCR, UK) and D3 CJ7, R1 from Inserm,Villejuif. Cells
were maintained undifferentiated on gelatin-coated tissue culture
plates in DMEM high glucose with glutamax (Invitrogen),
supplemented with 15% ES-qualified FBS (Hyclone), 0,5%
penicillin-streptomycin (Invitrogen), 100 mM 2-mercaptoethanol
(Invitrogen) and 1000 U/ml recombinant murine LIF (ESGRO,
Millipore).
Generation of IPSC lines
Murine IPS cell line M2A1 was generated by transduction of
5610
4 CD1 mouse embryonic fibroblasts with ectopic retroviral
particles carrying Oct4, Sox2, Klf4 and c-Myc vectors (Addgene).
After 3–4 weeks, ES-like colonies appeared and were individually
plucked. The individual clonal cells were then expanded and the
M2A1 cell clone was further characterized for pluripotency and
differentiation potential.
Human IPS cell lines were obtained by reprogramming
mesenchymal stem cells derived from H9 hES cells (H9-IPS)
(Figure S1).Adherent cells were characterized as MSC by flow
cytometry exploring the expression of CD105, CD73, CD90,
CD146, CD80, CD54 markers and the pluripotent markers Oct4,
Sox2, Nanog and Lin28 (Figure S2A). Multipotency of MSC was
tested for differentiation along the osteogenic, chondrogenic, and
adipogenic lineages (Figure S2 B–D) using Functional Identifica-
tion Kit (R&D Systems). Human iPSC were generated from
amniotic fluid cells (PB03, PB04, PB08, PB09, PB10) and
peripheral circulating endothelial progenitor cells (PB13). Amni-
otic fluid cells (AFC) and circulating endothelial progenitor cells
(EPC) were used after informed consent of patients. For each
human IPS cell line, 5610
4 to 1610
5 somatic cells were
transduced with either 4 VSVG-pseudotyped lentivirus carrying
Oct4, Sox2, Lin28 and Nanog vectors (Addgene) or 4 VSVG-
pseudotyped retrovirus carrying Oct-4, Sox-2, Klf-4 and c-Myc
vectors (Addgene). 4 to 6 weeks after transduction, undifferentiated
hES-like colonies were manually picked and expanded on
inactivated MEF in hESC medium. Colonies showed an ES
cell–like morphology and were analyzed for the expression of
pluripotent stem cell markers on a Macsquant flow cytometer with
MacsQuantify software (Miltenyi Biotech). Samples of 2.5610
5
cells were stained with a combination of FITC conjugated mouse
anti-human HESCA-1 antibody and PE conjugated mouse anti
human SSEA-4 antibody (Flow Cellect Human ESC Surface
Marker Characterization Kit, Millipore) according to the
manufacturer instructions. For TRA 1–60 expression assessment,
1610
5 cells were stained in 10 microliters of PBS with 1 microliter
of PE conjugated mouse anti human TRA 1–60 antibody or
1 microliter of unrelevant PE conjugated isotypic control (BD
Biosciences). ESC and iPSC stained positively Tra1–60, HESCA-
1 and SSEA-4 (Figure S3). Expression of exogenous transgenes
was measured by Q-RT-PCR. The IPSC had repressed the
transgenes and expressed the endogenous Oct4, Sox2, Nanog and
Lin28 genes (Figure S4).
iPSC formed mature teratomas containing tissues of all three
germ layers. Teratoma formation was induced by injection of
0.5610
6 to 3610
6 undifferentiated cells into the hind leg muscle of
NOD/SCID mice. Tumors were resected 6 to 8 weeks after
injection and immediately fixed in 4% paraformaldehyde in PBS
before paraffin embedding. Tumor sections were then stained with
hematoxylin and eosin before analysis for the presence of tissues
representative of the three germ layers (ectoderm, mesoderm and
endoderm).
The iPSC used in this study were in average at 20 passages and
had normal karyotype without genomic instability regions as
previously described [20]. ESC and iPSC lines were directly grown
on IR reflective slides (MirrIR, Kevley Technologies) in the
presence of Matrigel and mTeSR (Stem Cell Technologies) for
infrared spectroscopy analysis. ESC Colonies are represented in
Figure S5.
Generation of partially reprogrammed iPSC
Partially reprogrammed IPSC were established during attempts
to reprogram AFC. One iPSC (PB08-PR) were partially
reprogrammed using MIGR-Oct4, MIGR-Sox2, MIGR-Klf4
and MIGR-c-Myc retroviral vectors and characterized by GFP-
positive embryonic-stem-cell-like colonies. Three iPSC (PB14,
PB15, PB18) derived from AFC by lentiviral Oct4, Sox2, Nanog
and Lin28 vectors were also partially reprogrammed as they fail to
repress ectopic transgene factors (Figure S4).
Synchrotron radiation FTIR microspectroscopy
Primary AFC, MSC, ESC and iPS cell lines were grown on
MirrIR slides for 3 to 4 days prior to analysis by FTIR
microspectroscopy. Spectra were recorded at the SOLEIL synchro-
tron facility on the SMIS beamline which exploits the edge and
bending radiations of a bending magnet. The synchrotron delivers
300 mA current in the 4/4 filling mode, in top-up mode for
injection. Spectra were recorded in trans-reflexion on a Nicolet
Continuum XL microscope (Thermo Fischer, Courtaboeuf,
France) equipped with a 50650 mm
2 liquid nitrogen cooled
MCT/A detector, a 32X/NA 0.65 Schwarzschild objective, XYZ
motorised stage, and coupled to a Nicolet 5700 spectrometer
(Thermo Fischer, Courtaboeuf, France) equipped with a Michel-
son interferometer, and a KBr beamsplitter. The confocal aperture
was set at 12612 mm
2 which allowed measuring each individual
cell within the colonies with an infrared spot size matching their
size. The infrared spectrum of a stem cell is the overall signature of
the cell composition and fingerprints its physiological state
[21,22,23]. As proteins make up to 60–70% of the cell dry
weight, the spectra of stem cells are dominated by the signal of the
amide bands from the backbone of proteins, and show
contributions from other major constituents: nucleic acids, lipids,
and polysaccharides (Fig. 1A). For all cell lines, the spectra of 200
individual cells were collected for each of 3 independent cultures.
Representative spectra of the different classes of cells are shown in
Figure 1 and in Figure S5.
For individual cells, 128 to 256 scans per spectrum were
coadded at 4 cm
21 resolution with Happ-Genzel apodization, and
Mertz phase correction. All spectra were recorded between 800
and 4000 cm
21. To map entire colonies made of several
thousands of cells, data collection rate was increased by two
orders of magnitude by recording at 8 cm
21 resolution and 4–8
scans were coadded depending on colony size. Maps were
recorded by raster scanning the colony with steps of 10 microm
in X and Y, with the confocal aperture set at 12612 microm
2,
resulting in the collection of approximately one spectrum per cell.
Data analysis
Spectra of individual cells were analyzed by multivariate pattern
recognition techniques in The Unscrambler (Camo Software AS,
Oslo, Norway). Spectra were preprocessed before analysis:
Extended Multiplicative Scattering Correction (EMSC) was
applied between 800–1800 cm
21, and spectra were baseline
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800 cm
21 to eliminate baseline shifts after EMSC correction.
Alternatively, spectra were baseline corrected by subtracting a
linear baseline in the 800–1800 cm
21 and in the 2800–3100 cm
21
ranges, and were then normalized to the same area in the
concatenated ranges. In one case (iPS-PR, iPS-FR, AFC) the first
derivative was used to increase the discriminant power of the
method. The 800–1800 cm
21 range was found to be the most
relevant to separate amniocytes foetal cells from IPSC and ESC,
and IPSC from ESC, but the combined 800–1800 and 2800–
3000 cm21 range was more efficient for separating the differen-
tiated cells (MSC and MEF) from their embryonic counterparts,
and Fully Reprogrammed cells from Partially Reprogrammed
cells.
Since cells were grown to confluence and formed a flat layer,
little or no Mie scattering was observed. Spectra exhibiting Mie
scattering (less than 1% of the spectra) were eliminated from the
analysis.
The K-means clustering (KMC), Hierarchical Cluster Analysis
(HCA), Principal Component Analysis (PCA), Partial Least Square
Discriminant Analysis (PLS-DA) were carried out in the 800–
1800 cm




PCA were carried out using preprocessed, mean centered data,
8 principal components were calculated using the NIPALS
algorithm, and leverage correction was applied. Outliers were
identified and eliminated using the Hotelling T2 method, and the
residual versus leverage plot.
For PLS-DA, outliers were first eliminated by PCA. The
remaining spectra were split in 2 sets: a calibration set and a
smaller validation set containing a number of representative
spectra. A PLS-DA model was created on the calibration set using
the preprocessed, mean centered spectra. Random validation with
the dataset divided in 20 segments was performed, and 10 factors
were computed. A prediction was run on the validation set using 5
to 10 PLS-DA factors to use 98 to 99% of the explained spectral
variance. Spectra were considered as identified when their
prediction score was .0.5, and were considered as prediction
outliers when deviation was above 0.5.
In order to evaluate the performances of the PLS-DA
prediction, the sensitivity, specificity and the Matthews correlation
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(TPzFP)  (TPzFN)  (TNzFP)  (TNzFN)
p
where TP is the number of true positives, TN the number of true
negatives, FP the number of false positives, and FN the number of
false negatives.
The MCC is a correlation coefficient used to evaluate the
performance of binary classifications. It varies from 61t o0 ,+1
indicates a perfect identification, 0 is equal to the performance of a
random classification. Only binary PLS-DA classification models
were evaluated by the MCC.
The univariate analysis of the spectral maps was performed in
OMNIC 7.4 (Thermo Fischer, Courtaboeuf, France) by plotting
the area of one peak or the area ratio of two peaks. The
multivariate analysis was performed in Cytospec 1.0 (Cytospec
Inc., Boston, USA). by Hierchical Cluster Analysis HCA using D-
values (based on Pearson correlation coefficient) and Ward’s
method.
Supporting Information
Figure S1 Schematic experimental model of H9 Repro-
gramming. Pluripotency of H9 was lost by differentiation into
Mesenchymal Stem Cell lineage. Pluripotency was re-induced by
enforced expression of Oct4, Sox2, Nanog, Lin28 transgenes. ES-
like colonies was picked-up and characterized and defined as
iPSC-H9.
(TIF)
Figure S2 Expression of pluripotency markers in ESC
and iPSC by flow cytometry. FACS analysis of SSEA-4 and
HESCA-1 on H1, H9, HUES3,CL01, CL03, CL04 ESC (a–f),
PB03, PB04, PB08, PB09, PB10, PB13 (g–l), MSC-H9 before
reprogramming (m) and iPSC-H9 (n).
(TIF)
Figure S3 Expression of reprogramming factors by RT-
PCR. Oct-4, Sox2, Nanog and Lin28 gene expressions were
analysed in partially and fully reprogrammed iPSC and samples
were normalized relative to an endogenous RNA control (TBP
gene, which encodes TATA box-binding protein). For each
factors, PCR were performed whit sets of primers recognizing total
(endogenous and exogenous) and exogenous gene levels. Results
expressed as N-fold differences in target gene expression relative to
the TBP gene and termed ‘‘NTarget’’ were determined as
NTarget=2deltaCt sample, where the deltaCt value of the sample
was determined by substracting the average Ct value of the target
gene from the average Ct value of the TBP gene.
(TIF)
Figure S4 Typical spectral cartography of hESC-H9
colonies. H9 colonies were grown on slide and analyzed by
FTIR for their composition of Amides and Sugars/Amides or
lipids/Amide II. Ratios.
(TIF)
Figure S5 Representative spectra of different cell types.
Spectra were offset for clarity. (A) Representative spectra of ESC-
H9 cells illustrating the heterogeneity within one cell line. Nucleic
Acid (NA)-rich (blue), NA-poor (red), and NA intermediate (green)
spectra. (B) Average spectra of iPSC and AFC. Two representative
spectra of iPSC are shown to illustrate the heterogeneity in the
glycogen content of iPSC. (C) Average spectra of MEF (green),
murine ESC (blue) and iPSC (red). Two spectra of iPSC and ESC
are given to illustrate the similarity between different iPSC and
ESC and the difference with MEF. (D) Average spectra of MSC-
H9 (green), iPSC-H9 (red), and ESC-H9 (blue) cells. Two types of
spectra are shown for ESC and iPSC and illustrate the similarity of
the different iPSC and ESC spectral signatures.
(TIF)
Table S1 Peak assignment for the infrared spectral
signatures of stem cells.
(DOCX)
Table S2 Evaluation of the performances of PLS-DA
model binary classifications.
(DOCX)
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